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Traditionally, many of the major equine breed registries in the United
States recognize January 1 of the year a foal was born as that foals official birth
date. Thus, a foal born on March 1 and one born on August 23 would both be
considered a year old on the following January 1 even though there is a
considerable difference in their age. These two foals would compete on the
racetrack or ,in the show ring with the foal born earlier in the year having an
advantage. Therefore, it is desirable to breed mares so that foals will be born as
soon as possible after January 1. This poses a great challenge for reproductive
physiologists.
During the estrous cycle of the mare, one follicle is selected from a cohort
of follicles to become dominant. After selection the dominant follicle continues to
grow until ovulation, while the remaining cohort, or subordinate, follicles become
atretic and regress. Limited information is available regarding the physiological
mechanism of follicle selection and maturation in the mare. During preovulatory
development in the mare, follicular fluid IGF-I levels increase whereas IGFBP
levels decrease. In cattle, it has been hypothesized that estradiol and the
gonadotropins induce changes in the amount of IGF-I and IGFBPs produced by
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granulosa and thecal cells during follicular development. We hypothesize that, in
the mare, follicular development may involve steroid or gonadotropin induced
changes in the intrafollicular IGF system.
Therefore, the specific objectives of these experiments were to 1}
determine whether stage of the estrous cycle or follicle diameter influences
concentrations of steroids, as well as components of the IGF system, present in
follicular fluid of mares, 2) determine whether estradiol, insulin and/or FSH affect
steroid production by equine granulosa cells, and 3) determine what components
of the IGF system are produced by equine granulosa cells in culture, as well as
to determine whether estradiol, insulin and/or FSH affected IGF and/or IGFBP
production by equine granulosa cells.
CHAPTER /I
REVIEW OF LITERATURE
OVARIAN FOLLICULAR GROWTH AND DEVELOPMENT
The mare is a seasonally polyestrous, long day breeder with an ovulatory
season lasting from approximately May to October in the Northern Hemisphere
(Ginther, 1992). During the months of short daylength, or the anovulatory season
of the mare, follicular activity is suppressed. As daylength increases, follicular
activity, as indicated by an increase in the number and average diameter of
follicles, increases over a period' of several months (transitional period) until
ovulation. During this transition period, follicles grow and regress sequentially
(Ginther, 1979).
The estrous cycle of the mare lasts approximately 22 days (15 day
diestrus and' 7 day estrus) with ovulation occurring on the last day or two of
estrus (Ginther, 1979). Ovulation in the mare is unique in that it is limited to a
specific area on the ovary, the ovulation fossa, and is not triggered by a sudden
release of LH as seen in other mammalian species (Whitmore et aI., 1973). In
contrast, LH concentrations increase progressively during estrus and peak
approximately 1 day after ovulation (Whitmore et aI., 1973; Stabenfeld't et aI.,
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1975; Alexander and Irvine. 1982). The mare is also unique in that the number of
follicles involved in folliculogenesis is quite low compared to other species. For
example, Driancourt and co-workers (1982b) found that the ovaries of 2 to 4 year
old mares contained approximately 35,000 primordial and 100 growing follicles,
whereas cow ovaries contained 120,000 primordial and 280 to 435 gJOwing
follicles (Erickson, 1966) and ewes had approximately 56,000 primordial and 150
growing follicles (Cahill et al., 1979).
Follicular Waves
Mares, like cattle, are capable of producing one or two waves of follicular
activity during an estrous cycle (Evans and Irvine, 1975; Ginther, 1990). When
there are adequate amounts of circulating gonadotropins, follicles are recruited
from the reserve pool of small follicles (3 to 12 mm) to form major follicular
waves, or waves that develop a dominant follicle (Ginther, 1992). The wave
emerges as 6 mm follicles (n =5 to 6) on approximately day 12 or mid diestrus
and the follicles grow at similar rates until the largest follicle is about 23 mm. At
this point, the growth rates begin to differ and one follicle. the dominant follicle,
will continue to grow to approximately 35 mm in diameter, whereas the remaining
follicles regress (Ginther, 1992; Ginther, 1993). Divergence of the dominant
follicle is discussed in more detail in a later section of this review.
Major waves may be subdivided into primary and secondary waves.
Primary waves are major waves beginning during mid-diestrus with ovulation
occurring during estrus (Ginther, 1992). The day of emergence of a primary wave
occurs on average 6 days after ovulation, with day of emergence being the day
-
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before the diameters of growing follicles of a new wave exceed the diameters of
the regressing follicles from a previous wave (Ginther and Bergfelt, 1993). The
maximum diameter of the dominant follicle of a primary wave ranges from 36 to
53 mm (Ginther and Bergfelt, 1993). A secondary major wave may develop
during the end of estrus or early diestrus (Ginther, 1992). These secondary
waves occur in approXimately 42% of the ,interovulatory intervals, however, they
are more likely to occur in individual mares and some breeds (for review see
Ginther, 1992).
The dominant follicle of a wave either ovulates or anovulatory follicular
waves develop sequentially until conditions are right for ovulation to occur. The
dominant follicle of each wave causes the regression of the subordinate cohort
follicles and blocks the emergence of another wave until the dominant follicle
reaches a static phase (anovulatory wave) or approaches ovulation (ovulatory
wave) (Ginther, 1990). The mechanism by which the dominant follicle blocks
wave emergence is still unclear, but it has been suggested that the dominant
follicle produces a substance (inhibin or estradiol?) capable of suppressing
circulating FSH levels thus suppressing follicular development (Miller et aI., 1981;
Bergfelt and Ginther, 1985). Once the growth of the dominant follicle has
stopped, or ovulation approaches, another wave may emerge which contributes
to regression of the dominant follicle of the previous anovulatory wave or, if
ovulation has occurred, the new wave becomes the first wave of the
interovulatory interval (Ginther, 1990).
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Selection of the Dominant Follicle
As previously stated, approximately 12 days after ovulation a cohort
(n = 5 to 6) of similar-sized (approximately 6 mm), subordinate follicles will arise
(Ginther, 1979; Driancourt and Palmer, 1984; Pierson and Ginther, 1987). This
cohort will grow together until the time the ovulatory follicle is selected,
approximately 6 days prior to ovulation (Pierson and Ginther, 1987). Using a two-
follicle model that involved ablation of all follicles ~ 5 mm on Day 10 (Day 0 =
ovulation) to allow tracking of the two largest follicles, it was determined that the
future dominant follicle emerges approximately 1 day earlier than the future
subordinate follicle at an approximate diameter of 6 mm (Gastal et aI., 1997).
These two follicles (future dominant and largest subordinate follicle) grow in
parallel, with no significant difference in growth rates, until the future dominant
follicle reaches a diameter of approximately 21 to 23 mm. Once the future
dominant follicle reaches this critical diameter the growth rate of the smaller
follicle begins to decrease. This process is called selection or deviation (Gastal
et aI., 1997; Gastal et aI., 1999). Deviation begins and is fully established in less
than 1 day as indicated by the 1-day size advantage of the largest follicle over
the next largest follicle (Gasta I et aI., 1997), suggesting that when the la rgest
follicle reaches a critical diameter (21 to 23 mm in the mare), it inhibits the next
largest follicle before it reaches a similar critical diameter. At this time the
dominant follicle begins a period of accelerated growth until ovulation (Ginther,
1979; Palmer and Driancourt, 1980; Irvine, 1981; Ginther and Pierson, 1984;
Gastal et aI., 1997), while the second largest follicle undergoes atresia. Other
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large follicles not destined to ovulate begin to regress 6 to 7 days prior to
ovulation (Driancourt et aI., 1982a; Pierson and Ginther, 1987).
Studies in cattle (Ginther et aI., 1996; Ginther et aI., 1997) and mares
(Gastal et aI., 1997) indicate that when the larger follicle reaches a critical
diameter (21 to 23 mm in mares) it suppresses the next largest follicle before it
can reach the same diameter. The cause of this suppression is unclear, but
evidence suggests that low concentrations of FSH may playa role in the
deviation mechanism (for review see Ginther et aI., 1996). Specifically, it has
been suggested that the larger follicle suppresses FSH concentrations below the
concentrations required by the smaller follicle (Gastal et aI., 1999). This is
supported by studies indicating that exogenous FSH administered daily at the
onset of estrus (presumably prior to deviation) increases ovulation rate in mares
(Squires et aI., 1986; Rosas et aI., 1998). Similarly, circulating FSH
concentrations are low at the beginning of deviation (Bergfelt and Ginther, 1993;
Gastal et aI., 1997). It has not been determined if all follicles contribute to the
decline in FSH concentrations before deviation in the mare, but in cattle,
experimentally decreasing the number of follicles indicated that all growing
follicles contribute to the FSH decline after the time of wave emergence, but prior
to deyiation (Gibbons et aI., 1997). Involvement of estradiol in the deviation
mechanism has not been ruled out. Specifically, estradiol may function by
systemically inhibiting circulating FSH concentrations and by increasing LH
responsiveness by the larger follicle (for review see Ginther, 1996). However, LH
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is not directly involved in the initiation of deviation, but may playa role in growth
and maintanence of the dominant follicle after deviation (Gastal et aI., 2000).
Selection or deviation of the dominant follicle is not only a process of
selecting the ovulatory follicle, but it is also a process of selection against other
follicles in the cohort (Pierson and Ginther, 1990). Based on studies utilizing
follicle ablation and superovulation, it has been determined that prior to dominant
follicle selection, other follicles in the cohort are capable of dominance (Ginther et
aI., 1996; Gastal et aI., 1999). Furthermore, studies in cattle indicate that other
growing follicles of the wave are capable of becoming the dominant follicle if the
largest follicle is destroyed between the times of emergence and shortly after the
expected time of deviation (Ko et aI., 1991; Gibbons et aI., 1997). However, once
selection has occurred the remaining follicles in the cohort are committed to
atresia (Pierson and Ginther, 1990).
Initiation of Follicular Growth
The transformation of primordial to primary follicle appears to be an
extremely slow process of maturation rather than one of growth (Ginther, 1992;
Gougeon, 1996). Evidence in primates suggest that recruitment of primordial
follicles from the reserve pool of resting follicles begins by conversion of
flattened, squamous-type granulosa cells of primordial follicles into cuboidal,
epithelial type cells, thus increasing follicle diameter (Gougeon and Chainy,
1987; Gougeon, 1996). Moreover, the number and activity of granulosa cells in
9
relation to diameter of the oocyte at initiation appears to be highly species
specific (McNatty et al., 1999).
The signal for initiation of follicular growth remains to be elucidated,
however several hypotheses exist. In the mouse, inhibition of binding of the
tyrosine kinase receptor c-kit with its ligand, stem cell factor, prevents follicu4ar
initiation without blocking the formation of primordial follicles (Huang et aI., 1993;
Yoshida et aI., 1997). Moreover, administration of a c-kit antibody to mice
stopped granulosa cell proliferation (Yoshida et al., 1997), and initiation failed to
occur in mice mutant for the kit ligand gene despite the presence of primordial
follicles (Kuroda et aI., 1988; Huang et aI., 1993). Other studies in the mouse
suggest that initiation of follicle growth is dependent on collagen and laminin, but
not on activin-A (Oktay et aI., 2000). Research in sheep suggests that two major
genes are involved in growth initiation. Specifically, ewes homozyous for the
Inverdale prolificacy gene exhibit abnormal follicular and oocyte growth
suggesting that this gene influences initiation of follicular growth, particularly by
inhibiting growth at the primordial/primary stage (Bodensteiner et aI., 2000).
Furthermore, ewes homozygous for the Belclare gene are sterile due to an
alteration in granulosa cell proliferation (Reynaud et aI., 1999). Recent studies in
the primate suggest that androgen treatment increases the number of primary
follicles in the primate ovary perhaps by stimulating an increase in both IGF-I and
IGF-I receptors thus triggering oocyte development and initiation of follicle growth
(Vendola et aI., 1999). Further studies are needed to determine if any of these
mechanisms may be involved in initiation of follicular growth in the mare.
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Follicular Growth and Atresia
Follicular growth is initiated from a reserve of small follicles consisting of
resting follicles (follicles with an oocyte area smaller than 180 IJm2), transitional
follicles (follicles with an oocyte nuclear area between 180 and 250 IJm2 ) that
form a transitional population between the resting and growing follicles (follicles
with an oocyte nuclear area exceeding 250 IJm2 and a follicular area larger than
2000 IJm2 ; Driancourt et aL, 1982b). Follicular growth occurs by both proliferation
of granulosa cells and by an increase in the size of the oocyte (Gougeon, 1996).
As the primary follicle progresses toward a secondary follicle the stromal cells
near the basal lamina align parallel to one another, and the surrounding
connective tissue stratifies and differentiates into the theca externa (similar to the
undifferentiated cell type) and the theca interna (characterized by a change from
fibroblast-like precursor cells to epitheliod cells) (Gougeon, 1996). In equine
follicles a well-defined theca layer can not be detected until follicles reach 0.13
mm in diameter (Driancourt et aI., 1982b). Once epitheliod cells appear in the
theca interna, the follicle is no longer classified as a secondary follicle, but rather
a preantral follicle (Gougeon, 1996). When the follicle reaches a mean of
approximately 0.3 mm in diameter (Driancourt et aI., 1982b), formation of the
antral cavity begins by the development of small, fluid filled cavities that
aggregate to form the antrum (for review see Hillier, 1994). Antral formation is
dependent on stimulation by FSH, which acts via receptors on the granulosa cell
to stimulate cell division and synthesis of glycosaminoglycans, essential
components of follicular fluid (for review see Hillier, 1994). The number of these
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small antral follicles (2 to 5 mm follicles in the mare) is not constant throughout
the estrous cycle, but begins to increase around the time of ovulation (Pierson
and Ginther, 1987). Once the antrum forms the granulosa cells surrounding the
oocyte become known as the cumulus oophorus and the granulosa cells near the
basement membrane differentiate from cuboidal to columnar cells (Gougeon,
1996). Fluid accumulation within the antral cavity, and proliferation of granulosa
and theca interstitial cells continue until the follicle reaches a size suitable for
selection as the dominant follicle (25 to 30 mm in the mare; Pierson and Ginther,
1987; Gougeon, 1996).
The pituitary gonadotropins, LH and FSH, are important regulators of
folliculogenesis. Each follicle in the cohort of developing follicles must be
stimulated by FSH to begin development, otherwise it will undergo atresia (for
review see Hillier, 1994). Once the threshold for FSH stimulation is surpassed,
granulosa cell genes encoding aromatase, LH receptor and a.-inhibin are
increasingly expressed, mediated by second-messenger cyclic AMP (for review
see Hillier, 1994). The follicle with the lowest FSH threshold will become the first
follicle to produce estradiol (Hillier, 1981). Increasing estradiol will suppress FSH
secretion in a negative feedback mechanism with the hypothalamic-pituitary axis.
Circulating FSH levels will decrease to levels insufficient for development of other
follicles in the cohort (Hi.llier, 1981). Once the dominant follicle has been
selected, it is dependent on LH to maintain its status as dominant follicle. This is
accomplished through a paracrine signaling system that remains to be
elucidated; however inhibin has been implicated as an important factor (Hillier,
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1991). Toward the end of the follicular phase, plasma FSH levels begin to decline
and the LH surge suppresses granulosa cell proliferation and intitiates atresia of
subordinate follicles and luteinization of preovulatory follicles (for review see
Hillier, 1994).
Driancourt et al. (1982b) suggested that in the mare approximately 75% of
follicles are undergoing, atresia at any given time; however atresia was rarely
seen before follicles reached a medium antral size. The mechanism that
determines if a follicle is to become atretic remains to be determined.
Approximately six days prior to ovulation, coincident with the time of selection, all
follicles, with the exception of the dominant follicle, begin to regress (Ginther and
Pierson, 1984; Pierson and Ginther, 1987). It has been suggested that the
dominant follicle of each wave causes atresia of the cohort of subordinate
follicles and blocks emergence of the next follicular wave until ovulation occurs
(Ginther, 1990). Emergence of the next follicular wave induces regression of the
dominant follicle of an anovulatory wave (Ginther, 1990).
Follicular Steroidogenesis
Folliculogenesis is mainly under endocrine control of the pituitary
gonadotropins, LH and FSH (for reviews see Combarnous 1992; Adashi, 1994b;
Hillier, 1994). By binding to specific receptors on ovarian cells, the gonadotropins
stimulate synthesis and secretion of steroids that will act as endocrine and
paracrine regulators of gonadotropin levels. ovarian activity and follicular
development (for reviews see Gougeon, 1996). Steroidogenesis is dependent on
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the availability of cholesterol for conversion to pregnenolone, progesterone,
androgens and estrogens (for review see Conley and Baird, 1997). Steroidogenic
acute-regulatory protein (StAR) acts to transfer cholesterol from the outer
mitochondrial membrane to the inner mitochondrial membrane to allow the
enzymatic conversion of cholesterol to pregnenalone via cholesterol side-chain
c1evage (P450scc). Pregnenalone can then be metabolized by either the 64 or 65
pathway; the 64 pathway is preferential in equine follicles (Younglai and Short,
1970). The 64 pathway involves conversion of pregnenalone to progesterone via
3p-hydroxysteroid dehydrogenase (3PHSD). Progesterone is then converted to
androstenedione via 17a-hydroxylase (P45017o.) in the endoplasmic reticulum.
17P-hydroxysteroid dehydrogenase (17PHSD) then catalyses the conversion of
androstenedione to testosterone, which can then be converted to estrogen via
aromatase.
Steroidogenesis in the mare involves both granulosa and theca interna
cells as in the classic "two-cell theory" of follicular steroidogenesis (Senger,
1997). Briefly, when stimulated by LH the theca interna produces androgens that
are converted to estrogens in the granulosa cells when stimulated by FSH via the
aromatizing enzyme, aromatase. Granulosa cells in the mare follicle are
abundant in 3p-hydroxysteroid dehydrogenase (required for the conversion of
pregnenolone to progesterone) and aromatase (Jarrell and Robaire, 1982). The
presence of aromatase indicates that isolated granulosa cells are capable of
producing estradiol. In contrast, theca interna (Sirois et aI., 1991; Rodger et aI.,
1995), but not granulosa (Belin et aI., 2000) cells appear to be rich in enzymes
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such as cholesterol side-chain cleavage (P450sc:c), 17a-hydroxylase (P45017a),
and 3p-hydroxysteroid dehydrogenase (3PHSD), indicating that the theca interna
is the predominant site for androstenedione synthesis in equine preovulatory
follicles. The presence of P45017a in the theca interna (Sirois et aI., 1991; Rodger
et aI., 1995) of equine follicles is similar to observations in cattle (Arlotto et aI.,
1996), pigs (Conley and Baird, 1997; Tian et al., 1995) and sheep (Huet et aI.,
1997).
In many species, large dominant follicles are capable of producing large
amounts of estradiol-17P, whereas atretic follicles produce decreasing amounts
of estradiol-17P (cows - Ireland and Roche, 1982; pigs - Guthrie et aI., 1993;
humans - McNatty and Baird, 1978; Hillier et aI., 1981; sheep - Carson et aI.,
1981). Similarly in the mare, estradiol-17P and progesterone levels increase
during follicular growth, with maturation characterized by a decrease in estradiol-
17P and a further increase in progesterone levels (Gerard et aI., 1998; Gerard
and Monget, 1998; Belin et aI., 2000). Increased steroidogenic activity may be
the result of increased levels of steroidogenic enzymes such as P450scc , 3pHSD
and aromatase (Belin et al.. 2000). Moreover, subordinate follicles are
characterized by a decrease in P450scc , 3pHSD and aromatase, as well as
decreased levels of estradiol-17P and progesterone (Almadhidi et aI., 1995;
Gerard and Monget, 1998; Belin et aI., 2000). Thus, it appears that changes in
intrafollicular steroids during tolliculogenesis are determined by expression of the
various steroidogenic enzymes (Belin et aI., 2000).
-
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OVARIAN INSULIN-LIKE GROWTH FACTORS, THEIR BINDING
PROTEINS, AND RECEPTORS
Follicular development is controlled by numerous endocrine and paracrine
factors. Of the paracrine factors involved, the insulin-like growth factor system
has been implicated in modulation of gonadotropin action on proliferation and
differentiation of granulosa and thecal cells (Monget et aI., 1996). The IGF
system is composed of the following
• two ligands, IGF-I and -II (Humbel, 1990)
• two receptors, a type I receptor responsible for mediation of IGF-I and -II
action (Roth and Kiess, 1994), and a type II receptor or IGF-ll/mannose-6-
phosphaste (IGF-II/M6P) receptor that appears to be involved in IGF-II
degradation (Monget and Bondy, 2000).
• at least six high affinity binding proteins (IGFBP-1 through -6) (Rajaram et aI.,
1997).
Insulin-like Growth Factor (IGF)-I and -II
IGF-I and -II were first isolated from human serum by Rinderknecht and
Humbel in 1978 (Rinderknecht and Humbel, 1978a,b). Both are single chain
polypeptides with three intrachain disulfide bonds. IGF-I consists of 70 amino
acids with a molecular mass of 7.65 kDa, while IGF-II consists of 67 amino acids
with a molecular mass of 7.47 kDa. IGF-I and -II are over 60% homologous with
each other but less homologous with insulin and its precursor, proinsulin.
Furthermore, the amino acid sequence of both IGF-I and -II are highly
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homologous (i.e., >90%) across species (Spicer and Echternkamp, 1995). IGF-I,
-II and proinsulin are all composed of A and B insulin regions joined by two
disulfide bonds and a connecting C-peptide. The IGF-I gene is expressed as a
prepro IGF-I that requires post-translational modification to clip off both the amino
terminal signal peptide and the carboxy terminus E peptide to produce the 70
amino acid form of IGF-1 common in biological tissues and fluids (for reviews see
Baxter, 1988b; Rosenfeld et aI., 1990). The human IGF-I gene is approximately
100 kilobases found on the long arm of chromosome 12 (Brissenden et aI., 1984;
Tricoli et al., 1984) whereas the human IGF-U gene is on the short arm of
chromosome 11, near the insulin gene, and consists of approx'imately 30
kilobases (Brissenden et aI., 1984; Tricoli et aI., 1984; Bell et aI., 1985).
Both IGF-I and IGF-II are synthesized and secreted in a wide variety of
organs and tissues including the ovary. The IGFs have been detected in follicular
fluid of pigs (Spicer et aI., 1992; Echternkamp et aI., 1994b), cattle (Spicer et aI.,
1988; Spicer and Enright, 1991; Kirby et aI., 1993), mares (Spicer et aI., 1991),
women (Jesionowska et al., 1990) and sheep (Spicer et aI., 1995). Moreover,
IGF-I and -II mRNA have been detected in ovarian tissue of cattle (Einspanier et
aI., 1990; Spicer et aI., 1993; Yuan et aI., 1998), human (Voutilainen and Miller,
1987; Barreca et aI., 1993; EI-Roeiy et aI., 1993; EI-Roeiy et aI., 1994), sheep
(Spicer et aI., 1995), pigs (Samaras et aI., 1994) and rats (Murphy et aI., 1987;
Hernandez et aI., 1989; Oliver et aI., 1989). Specifically, in rats. IGF-I mRNA is
found almost exclusively within granulosa cells, whereas IGF-II mRNA is found in
thecal cells (Hernandez et aI., 1989; Oliver et aI., 1989). IGF-I mRNA has been
-
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found in granulosa cells of pigs (Hatey et aI., 1992) and in both granulosa and
thecal cells of cattle (Spicer et aI., 1993; Spicer and Echternkamp, 1995).
Moreover, granulosa cells of cattle (Spicer et aI., 1993; Spicer and Chamberlain,
2000) and pigs (Hsu and Hammond, 1987a,b) secrete IGF-1.
In addition to being species specific, the IGF gene is expressed in a cell-
specific pattern that is dependent on the developmental stage of the follicle
(Lucy, 2000). For example, IGF-I gene expression is localized within the
granulosa cells of healthy, developing follicles in mice (Adashi et aI., 1997), with
maximum levels found in granulosa cells of lar9'e preantral follicles and in the
cumulus of small antral follicles (Wandji et aI., 1998). Moreover, small antral
follicles «4 mm) of cattle (Echternkamp et aI., 1990; Spicer and Enright, 1991)
and pigs (Hammond et aI., 1988; Spicer et aI., 1992; Echternkamp et aI., 1994b)
had lower concentrations of IGF-I than did large (>5 mm ) antral follicles, and
IGF-I and -II mRNA were greater in granulosa cells of dominant bovine follicles
than in subordinate follicles during the first follicular wave (Yuan et aI., 1998).
Studies in IGF-I knock-out mice suggest that an increase in IGF-I gene
expression in large preantral follicles stimulates an increase in FSH receptors
and an increase in type I IGF receptors which ultimately amplify FSH action,
formation of the antrum, and expression of aromatase and LH receptors in fully
differentiated follicles (Zhou et aI., 1997). This positive feedback loop has also
been seen in sheep (Perks et aI., 11995) and cattle (Wandji et aI., 1992). In
contrast, IGF-I mRNA did not change as follicles grew from 2 to 8 mm
(preovulatory size) in weaned sows; however, IGF-II mRNA increased as follicles
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developed to 6 mm in diameter, but then decreased as follicles developed to 8
mm in diameter (Liu et aI., 1999). These results are similar to those found in
cyclic sows where IGF-I mRNA levels.did not change from small to large antral
follicles, while IGF-II mRNA levels increased as follicles grew (Yuan et aI., 1996).
In vitro, IGF-I stimulates both granulosa and thecal cell proliferation and
differentiation of several species (for review see Giudice, 1992; Monget and
Monniaux, 1995; Spicer and Echternkamp, 1995). Specifically, IGF-I acts
synergistically with gonadotropins to enhance progesterone and(or} estradiol
production by granulosa cells of cattle (Spicer et aI., 1993; Armstrong et aI.,
1996; Spicer and Chamberlain, 1999), humans (Erickson et aI., 1989; Iwashita et
aI., 1996) and rats (Adashi et aI., 1984). In the absence of FSH, IGF-I is a weak
stimulator of steroidogenesis but potent stimulator of granulosa cell proliferation
(Spicer et aI., 1993; Armstrong et aI., 1996; Spicer and Chamberlain, 1999). It
has been hypothesized that the IGF-I induced FSH amplification may distinguish
follicles destined to ovulate from those destined for atresia (Adashi, 1994a). In
recent in vitro studies, IGF-I in combination with FSH decreased the occurrence
of spontaneous apoptosis in porcine granulosa cells (Guthrie et aI., 1998). IGFs
may be required for entry of follicles into the pool of growing follicles and for their
gonadotropin-independent development, whereas, entry of follicles into the
gonadotropin-dependent stage of follicular development may require an increase
in FSH receptors and/or type IIGF receptors in cattle (Wandji et aI., 1992), and
IGF-II and/or type-I IGF receptors in sheep (Perks et aI., 1995). Studies utilizing
IGF-I null mice supply the first real evidence of the involvement of the IGF
19
system in folliculogenesis and fertility. These studies ind'icate that IGF-~ is
permissive but not crucial for the recruitment of primordial follicles, the growth of
preantral follicles, and cell proliferation, at least up to the antral stage of follicular
development (Baker et aI., 1996). Similar results have been found in cattle
(Gong et aI., 1991; Chase et aI., 1998).
Insulin-like Growth Factor Binding Proteins
IGFBP-1 through -6 share -35% sequence identity with one another
(Rajaram et aI., 1997). They each contain a cysteine rich region at both the
amino and carboxy terminal regions of the protein as well as 18 conserved
cysteines (with the exception of human IGFBP-2 which has 20) arranged in
approximately the same spatial configuration (Rosenfeld et aI., 1990 ).
Conservation of this spatial configuration is indicative of a well-conserved
secondary structure of the IGFBPs (Rosenfeld et al., 1990). There is also a
conserved Arg-Gly-Asp sequence near the carboxy terminal of all IGFBPs with
the exception of human IGFBP-3 (Rosenfeld et aI., 1990). However, there are
significant differences in the "spacer" regions between the conserved cysteines
as well as in the signal peptide sequences and in glycosylation of the IGFBPs
(Wood et aI., 1988; Zapf et aI., 1988; Lamson et aI., 1989b). The IGFBP genes
are members of a large gene family (Rosenfeld et aI., 1990) with human IGFBP-1,
and -3 genes located on chromosome 7 (Ehrenborg et aI., 1992), IGFBP-2 and-
5 on chromosome 2 (Allander et a\., 1993; Allander et aI., 1994), and IGFBP-4
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and -6 on chromosomes 17 and 12, respectively (Ehrenborg et at, 1992;
Allander et al., 1994).
IGFBP-1
IGFBP-1 is a 25 to 34 kDa ( for review see Spicer and Echternkamp,
1995) nonglycosylated, acid stabile protein (Ooi and Herington, 1988) first
isolated from mid term human amniotic fluid (Drop et aI., 1979). It binds IGF-I
and -II with equal affinity and acts to inhibit and/or potentiate IGF action
(Rajaram et aI., 1997). The amino acid sequence of IGFBP-1 consists of 12 N-
terminal and 6-C terminal cysteine residues (Lee et aI., 1997) and is 68 to 72%
homologous among cattle, mice, rats and humans (Chamberlain, 1999). The
amino acid sequence of equine IGFBP-1has not been determined.
IGFBP-1 is the primary binding protein in amniotic fluid (Giudice et aI.,
1991) and is also present in human plasma (Rabinovici et aI., 1997), serum
(Hartshorne et aI., 1990) and follicular fluid (Harstshorne et aI., 1990), as well as
milk, urine, synovial fluid, interstitial fluid and seminal fluid of humans (for review
see Rajaram et aI., 1997). IGFBP-1 mRNA has been localized in the placenta
(Brewer et aL, 1988; Lamson et aI., 1989b) and some breast cancer cell lines
(Yee et aI., 1989) of women, and is the most prominently expressed IGFBP in
decidualized, and to a lesser extent secretory, endometrial tissue (Brewer et aI.,
1988).
Although IGFBP-1 is present in follicular fluid, only a few studies have
been conducted to determine if the ovary or follicle produce it. IGFBP-1 is
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present in the ovary of women, butto date has not been identified in ovarian
tissue of other species. IGFBP-1 has been found in human luteinized cells of
hyperstimulated preovulatory follicles and cells of the corpus luteum (Seppala et
aI., 1984). In vitro, IGFBP-1 has been found in cultured human stromal and
thecal cells (Mason et aI., 1991), luteinized granulosa cells (Suikkari et aI., 1989;
Giudice et aI., 1991), and in human granulosa cell-conditioned medium (Suikkari
et aI., 1989). Human granulosa-luteal cells contain and express mRNA for
IGFBP-1 (Seppala et aI., 1984; Giudice et at, 1991) whereas thecal cells contain
IGFBP-1 mRNA, but not the protein (Jalkanen et aI., 1989). IGFBP-1 is not
produced by porcine granulosa ceUs, nor has IGFBP-1 mRNA detected by
Northern blot analysis (Grimes et aI., 1994a). Because human granulosa cells
contain and express IGFBP-1 mRNA it is likely that these cells contribute to the
amount of IGFBP-1 present in follicular fluid, at least in women.
IGFBP-2
IGFBP-2 is a 29 to 40 kDa (for review see Spicer and Echternkamp, 1995)
nonglycosylated, acid stabile protein (Ooi and Herington, 1988) first isolated in
from rat liver (BRL)-3A cell line (Mottola et aI., 1986). It binds IGF-II with greater
affinity than IGF-I and acts as an inhibitor of IGF action (Rajaram et aI., 1997).
The amino acid sequence of IGFBP-2 is 64 to 92% homologous among cattle,
mice, rats, pigs, humans and sheep (Chamberlain, 1999). The amino acid
sequence of equine IGFBP-2 has not been determined.
IGFBP-2 is the primary binding protein in the central nervous system,
cerebrospinal fluid (Binoux et aI., 1982) and in neonatal rat serum (Giudice et aI.,
-
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1991). It has also been found in adult rat serum (Shimasaki etal., 1991b), human
milk, follicular fluid and seminal plasma (Binoux et aI., 1991a,b), rat brain and
cultured neuron and glial cells (Lamson et aI., 1989a), as well as bovine
endometrium and, to a lesser extent, myometrium (Kirby et a'l., 1996).
Because IGFBP-2 is present in follicular fluid, other studies have been
conducted to determine if the ovary or follicle produce it. IGFBP-2 mRNA is the
primary binding protein mRNA present in the human ovary and is localized within
both granulosa and thecal cells (Voutilainen et aI., 1996). Moreover, IGFBP-2
has been detected in human granulosa cell conditioned media (Cwyfan Hughes
et aI., 1997). In cattle, IGFBP-2 mRNA has been localized to granulosa cells
(Yuan et aI., 1998) and cells of the corpus luteum (Kirby et aI., 1996), whereas
IGFBP-2 protein has been detected in both granulosa and thecal cells (Funston
et aI., 1996) as well as bovine follicular fluid. In other species, IGFBP-2 mRNA
has been localized within granulosa and thecal cells and corpora lutea of pigs
(Samaras et aI., 1992) and sheep (Perks and Wathes, 1996) and in theca
intersitial and secondary interstitial cells of the rat (Nakatani et aI., 1991).
Collectively, these findings suggest that IGFBP-2 produced by follicular cells
contribute significantly to follicular fluid concentrations of IGFBP-2.
IGFBP-3
IGFBP-3 is a 28 kDa to 53 kDa (Wood et aI., 1988; Spicer and
Echternkamp, 1995) N-glycosylated protein, and is the major IGFBP present in
human circulation (Baxter et aI., 1986) and follicular fluid (Cataldo and Giudice,
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1992a). In circulation, IGFBP-3 forms a 150- to 200-kDa complex consisting of
IGFBP-3, IGF- I or -U and an acid-labile subunit (Baxter, 1988a; Baxter, 1990).
IGFBP-3 binds IGF-I and IGF-II with equal affinity and acts as an inhibitor and/or
potentiator of IGF action (Rajaram et aI., 1997). The amino acid sequence of
IGFBP-3 is 78 to 89% homologous among cattle, mice, rats, humans and pigs
(Chamberlain, 1999). The amino acid sequence of equine IGFBP-3 has not been
determined.
In mammals, IGFBP-3 is present in serum, follicular fluid, milk, urine,
cerebrospinal fluid, amniotic fluid, synovial fluid, interstitial fluid and seminal fluid
(for review see Rajaram et aI., 1997). The main site of IGFBP-3 gene expression
is in the liver (Wood et aI., 1988) but has also been detected in bovine (Kirby et
aI., 1996) and human (Lamson et aL, 1989b) endometrium.
Because IGFBP-3 is present in follicular fluid, numerous studies have
been conducted to determine if the ovary or follicle produce it. In humans,
IGFBP-3 is present in granulosa (Cataldo et aI., 1993) and thecal (Hughes et aI.,
1997) cells, thecal conditioned media, and atretic follicles (Cwyfan-Hughes et aI.,
1997). IGFBP-3 mRNA has been localized in cultured human granulosa cells
(Giudice et aI., 1991), as well as granulosa and thecal cells of dominant human
follicles (EI-Roeiy et aI., 1994). However, in small antral follicles of women
IGFBP-3 mRNA has been detected only in thecal cells (EI-Roeiy et aI., 1994). In
rats, IGFBP-3 mRNA has been detected in regressing corpora lutea (Erickson et
aI., 1993), but not in granulosa or thecal cells (Nakatani et at, 1991). Localization
of IGFBP-3 mRNA in the porcine ovarian compartment is similar to that of the rat
-
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except that low levels of lGFBP-3 mRNA have been detected in thecal cells
(Samaras et aI., 1992) and IGFBP-3 protein is produced by porcine granulosa
cens (Grimes et aI., 1994a). In cattle, IGFBP-3 mRNA is localized in granulosa
but not thecal cells of small antral follicles (Yuan et aI., 1998). Because follicular
fluid levels of IGFBP-3 remain constant throughout the human menstrual cycle-
(Cataldo and Giudice, 1992b; Huang et aI., 1994) and the estrous cycle of pigs
(Grimes et aI., 1994b), cattle (Echternkamp et al., 1994a; de la Sota et at, 1996;
Funston et aI., 1996; Stewart et aI., 1996), sheep (Monget et aI., 1993; Spicer et
aI., 1995) and horses (Gerard and Monget, 1998), it is unlikely that intrafollicular
production of IGFBP-3 contributes significantly to the amount of IGFBP-3 present
in follicular fluid.
IGFBP-4
IGFBP-4 is a 25 to 30 kDa (for review see Spicer and Echternkamp, 1995)
nongycosylated protein first isolated from human osteosarcoma TE-89 cell
conditioned medium (Mohan et aI., 1989) and from adult rat serum (Shimonaka
et aI., 1989). IGFBP-4 binds IGF-I and IGF-II with equal affinity and acts as an
inhibitor of IGF action (Rajaram et aI., 1997). The amino acid sequence of
IGFBP-4 is 88 to 98% homologous among cattle, pigs, mice, rats, humans and
sheep (Chamberlain, 1999). The amino acid sequence of equine IGFBP-4 has
not been determined.
IGFBP-4 has been detected in serum, follicular fluid, seminal fluid,
interstitial fluid and synovial fluid (for review see Rajaram et aI., 1997) as well as
-
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conditioned media of normal human osteoblast-Jike cells (Mohan et aI., 1989),
fibroblasts (Camacho-Hubner et aI., 1992), endometrial stromal cells (Irwin et aI.,
1995) and neuroblastoma cells (Fielder et aI., 1990; Cheung et aI., 1991).
Because IGFBP-4 is present in follicular fluid, other studies have been
conducted to determine if the ovary or follicle produce it. Within the human
ovary, IGFBP-4 protein is primarily localized in granulosa cells of atretic follicles
(Cataldo et aI., 1993; Liu et aI., 1993;. Voutilainen et aI., 1996), but has also been
detected in granulosa and thecal cells of antral follicles of polycystic ovarian
syndrome women (EI-Roeiy et aI., 1994). IGFBP-4 mRNA has been localized in
granulosa and thecal cells of large (14 mm) human follicles, but is more
abundant in granulosa cells of small (11 mm) follicles (Voutilainen et aI., 1996).
In addition, IGFBP-4 mRNA has been detected in human luteal cells and in
oocytes from preantral to antral stages of development (Peng et aI., 1996). In
rats, IGFBP-4 protein is found in granulosa cells of atretic follicles and IGFBP-4
mRNA was weakly expressed in dominant follicles (Liu et aI., 1993). In pigs,
IGFBP-4 protein is present in atretic follicles as well as small healthy follicles
(Besnard et aI., 1997). Porcine IGFBP-4 mRNA has been localized to thecal cells
of medium size growing follicles, luteinizing granulosa cells (Gadsby et aI., 1996;
Zhou et aI., 1996) and luteal cells (Zhou et aI., 1996). In sheep, IGFBP-4 mRNA
has been localized in both granulosa and thecal cells of dominant follicles
(Besnard et aI., 1996a). IGFBP-4 mRNA has also been detected in granulosa
and thecal cells of atretic bovine follicles (Armstrong et al., 1998). Therefore, it is
likely that intrafollicular production of IGFBP-4 contributes significantly to the
-
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amount of IGFBP-4 present in follicular fluid; however, species differences exist.
Moreover, IGFBP-4 is likely a key factor in follicular atresia.
IGFBP-5
IGFBP-5 is a 29 to 31 kDa (for review see Spicer and Echternkamp, 1995)
O-linked glycosylated (Conover and Kiefer, 1993) protein first isolated from adult
rat serum, human bone extract and U-20S human osteosarcoma cell line
conditioned medium (Shimasaki et aI., 1991a; Bautista et aI., 1991). IGFBP-5
binds IGF-II with greater affinity than IGF-I and acts as a potentiator of IGF action
(Rajaram et al., 1997). The amino acid sequence of IGFBP-5 is 97 to 99%
homologous among cattle, mice, rats, pigs and humans (Chamberlain, 1999).
The amino acid sequence of equine IGFBP-5 has not been determined.
IGFBP-5 has since been detected in serum, follicular fluid and
cerebrospinal fluid (for review see Rajaram et aI., 1997) and mRNA has been
localized in numerous cells and tissues including rat liver, brain, lung, adrenal,
spleen, heart, kidney, intestine, stomach and testis homogenates (Erickson et aI.,
1992), and human fibroblasts (Camacho-Hubner et aL, 1992) and osteoblast
(Conover and Keifer, 1993; Canalis and Gabbitas, 1995) cells.
Because IGFBP-5 is present in follicular fluid, other studies have been
conducted to determine if the ovary or follicle produce it. IGFBP-5 mRNA has
been detected in human granulosa and thecal cells (Voutilainen et aI., 1996). In
pigs, IGFBP-5 protein is secreted by granulosa cells (Grimes et aI., 1994a),
however, no IGFBP-5 mRNA has been detected in porcine follicles (Zhou et al.,
-
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1996), suggesting that in pigs IGFBP-5 is not an important IGFBP in terms of
follicular selection or function. In sheep, IGFBP-5 mRNA has been localized in
granulosa cells of atretic follicles and thecal cells of healthy follicles (Besnard et
aI., 1996a). Similarly in the rat, IGFBP-5 mRNA is present in granulosa cells of
atretic follicles, secondary interstital cells and luteal cells (Erickson et aI., 1992).
Moreover, IGFBP-5 mRNA has been detected in cultured rat granulosa cells (Liu
et aI., 1993). Therefore, It is likely that intrafollicular production of IGFBP-5
contributes significantly to the amount of IGFBP-5 present in follicular fluid;
however, species differences exist.
IGFBP-6
IGFBP-6 is a 21 to 32 kDa (for review see Spicer and Echternkamp, 1995)
O-glycosylated (Shimasaki et aI., 1991 a) protein first purified from transformed
human fibroblast cell cultures (Martin et aL, 1990) and from human cerebrospinal
fluid (Bach et aI., 1992; Bach et aI., 1994). IGFBP-6 binds IGF-II with greater
affinity than IGF-I and acts as an inhibitor of IGF action (Rajaram et aI., 1997).
The amino acid sequence of IGFBP-6 is 67 to 83% homologous among cattle,
rats, mice, and humans (Chamberlain, 1999). The amino acid sequence of
equine IGFBP-6 has not been determined.
IGFBP-6 is primarily found in humans and rats. It has been localized in
many body tissues and fluids including serum (Zapf et a!., 1990), retinal pigment
epithelial cells (Feldman and Randolph, 1994), prostate cancer cells (Srinivasan
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et aL, 1996), osteoblasts (Gabbitas and Canalis. 1997), amniotic fluid (Rajaram
et aL, 1997) and bovine mammary epithelial cells (Cohick and Turner, 1998)
IGFBP-6 mRNA has been localized in human granulosa, thecal and
stromal cells (Voutilainen et aL, 1996) and rat granulosa and thecal interstitial
cells (Rohan et aL, 1993). Although IGFBP-6 is present in porcine follicular fluid
(Shimasaki et aL, 1990), IGFBP-6 is not produced by porcine granulosa cells
(Grimes et aL, 1994a). Moreover, IGFBP-6 mRNA has not been detected in
porcine granulosa cells by Northern blot analysis (Grimes et aI., 1994a). This
suggests that in swine, intrafollicular levels of IGFBP-6 are most likely produced
by other types of follicular cells. To date, IGFBP-6 does not appear to be a major
contributor to intraovarian IGFBP content in most species.
NewlGFBPs
Recently, several new gene products have been suggested to be part of
the IGFBP family. The mac25 gene, encoding a 277 amino acid preprotein, has
been cloned and sequenced from leptomeningial and mammary epithelial cells
(Swisshelm et aL, 1995). The mature protein has not yet been identified I but the
deduced amino acid sequence of the mac25 propeptide shows 40 to 45%
similarity and 20 to 25% identity to IGFBPs (Oh et aL, 1996). The mac25
propeptide contains the common IGFBP motif (GCGGCCx.xC) at the amino
terminus, in an area containing a cluster of 12 conserved cysteines, 11 of which
are found in mac25 (Oh et aI., 1996). Thus, mac25 meets structural criteria to be
considered another member of the IGFBP family. Moreover, mac25 specifically
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binds IGF-I and -II and insulin, but with rather low affinity (Oh et aI., 1996).
Therefore, mac25 has been named IGFBP-7. Sim'ilarly, a family of closely related
gene encoding connective tissue growth factor (CTGF; Bradham et at, 1991),
the nov oncogene (Martinerie et aI., 1992) and cyr61 (O'Brien et aI., 1990) have
been identified and suggested to be members of the IGFBP family. These
proteins have 30 to 38% sequence identity with IGFBP-1 through-6.
Furthermore, these proteins contain the characteristic 'IGFBP motif
(GCGCCXXC) in their amino terminus and 17 of the 18 cysteines are conserved
(Bork, 1993). OTGF has also been found to bind IGF-I and -II, although with
relatively low affinity (Kim et aL, 1997). CTGF, nov, and cyr61 have been named
IGFBP-8, -9 and -10, respectively (Kim et aI., 1997). However, Baxter and
coworkers (1998) have suggested that these proteins not be named IGFBPs, but
insulin-like growth factor-related proteins (IGFBP-rP) until their molecular,
biochemical and physiological relationships can be more closely related to the
IGFBPs.
IGFBP actions within the ovary
In gleneral, each IGFBP has a specific function that is determined by
structural differences of the binding protein (for example, glycosylation, number
of cysteines, RGD sequence), binding affinity and tissue-specific expression
(Rajaram et al., 1997). In particular, each IGFBP may either stimulate or inhibit
IGF action depending on posttranslational modifications such as phosphorylation
(Koistinen et aI., 1993), proteolysis and cell surface association (Hossenl,opp et
-
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aI., 1990; Conover, 1992; Frost et aI., 1993; Lalou and Binoux, 1993; Liu et aI.,
1993). These factors act by altering the binding affinity of the IGFBPs to IGF
(Rajaram et aI., 1997) thus increasing (Elgin et aI., 1987) and/or decreasing:
(Ritvos et aI., 1988; Knauer and Smith, 1980) the responses of cells to the IGFs,
suggesting that IGFBPs regulate the bioavailability of IGFs to their target tissues
(Hardouin et aI., 1989). For the most part, IGFBPs function to inhibit IGF action
by sequestering free IGF thus preventing it from binding to its receptor (Rechler,
1993). When bound to IGF, the JGFBPs also function to increase the half-life of
IGF thus creating large pools of IGFs within the body (Monget et aI., 1996;
Monget and Bondy, 2000) and maintaining the high levels of IGF in circulation by
limiting their transport out of the vasculature (Conover, 1996).
The IGFBPs have al:so been suggested to act as antigonadotropins by
sequestering endogenous IGF, therefore limiting optimal FSH action (for review
see Adashi, 1998). Specifically, IGFBP-2, -3, -4 and -5 are potent inhibitors of
FSH, but not LH, stimulated steroidogenesis in cultured rat granulosa cells (Ui et
aI., 1989; Bicsak et aI., 1990; Liu et aI., 1993). However, IGFBP-3 had no effect
on FSH-induced progesterone or estradiol production by culture bovine
granulosa cells (Spicer and Chamberlain, 1999). Rather, IGFBP-3 inhibited IGF-I
induced progesterone and estradiol production by bovine grc;lnulosa cells (Spicer
and Chamberlain, 1999). In bovine thecal cells, IGFBP-2 and -3 inhibited IGF-I
induced (but not LH induced) progesterone and androstenedione production
(Spicer et aI., 1997). Conversely, FSH has been found to decrease ovarian
expression of the low molecular weight binding proteins in growing healthy
-
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follicles; whereas atretic follicles are characterized by a loss of sensitivity to
gonadotropins that allows an increase in expression of the low molecular weight
binding proteins (Monget et aI., 1996). Specifically, within the granulosa cells of
the rat (Uu et aI., 1993), FSH substantially inhibits production of the IGFBPs.
Similarly, FSH has been found to inhibit bovine granulosa cell IGFBP-2 gene
expression (Armstrong et aI., 1998; Schams et aI., 1999). However, in the mouse
FSH had no effect on granulosa ceIlIGFBP-4 or-5 (Adashi et aI., 1997),
suggesting species specificity regarding follicular IGFBP production. Inhibition of
IGFBP production may serve to increase free IGF resulting in a stimulatory effect
on follicular development (for review see Adashi, 1998).
Estradiol also influences intraovarian IGFBP synthesis, but it appears to
affect each IGFBP differently. For example, estradiol decreases IGFBP-1 protein
and mRNA levels in human luteinizing granulosa cells (Iwashita et aI., 1996).
Estradiol increases IGFBP-2 mRNA in rat theca-interstitial cells (Ricciarelli et aI.,
1991), but decreases IGFBP-2 protein synthesis in rat (Ricciarelli et aI., 1991)
and pig (Mondschein et all., 1990) granulosa cells. Furthermore, I,GFBP-2 levels
decrease with increases in estradiol concentrations in human (San Roman and
Magoffin, 1993), bovine (Echternkamp et aI., 1994a; Funston et aI., 1996;
Stewart et aI., 1996), porcine (Howard and Ford, 1992), and.ovine (Spicer et aI.,
1995) follicular fluid. Estradiol does not affect IGFBP-3 or -4 production by
porcine granulosa cells (Mondschein et aI., 1990). However, diethylstilbesterol
(DES) increased IGFBP-4 (Ricciarelli et aI., 1991), but decreased IGFBP-6
(Rohan et aI., 1993) mRNA in hypophysectomized rats. In comparison, insulin
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decreases IGFBP-1 transcription in rats (Orlowski et at., 1991) and humans
(Powell et aI., 1991), but incre'ases IGFBP-2 (Grimes and Hammond, 1992;
Samaras et al., 1993) and -3 (Grimes and Hammond, 1992) production in
cultured porcine granulosa cells.
Insulin-like Growth Factor Receptors
The IGFs act by binding to and activating specific membrane bound
receptors present on most cells (Conover, 1996). The type IIGF receptor is a
a2p2 tetramer, both structuralfy and functionally related to the insulin receptor
(Roth and Kiess, 1994), that mediates most actions of IGF-I and -II through the
classical growth factor signaling cascade involving activation of the tyrosine
kinase domain of the receptor (LeRoith et al., 1995; Stewart and Rotwein, 1996).
It is synthesized on the ribosome as a single polypeptide chain. Post-translational
modifications remove a 3D-amino acid signal peptide and cleave off the
proreceptor into a 706-amino acid extracellular a-subunit and a 626-amino acid
transmembrane J3-subunit . The a- and f3-subunits are linked by disulfide bonds
I
to form a aJ3-half-receptor; two aJ3-half-receptors are then joined by disulfide
bonds to form the mature a2J32 - holoreceptor. The cysteine-rich a-subunit
extracellular domain provides the ligand binding specificity, whereas, the
cytoplasmic f3-domain provides the tyrosine kinase activity (for review see
Werner et aI., 1991). The cysteine rich area of the type IIGF receptor is
necessary for recognition of IGF-I by the receptor (Andersen et aI., 1991;
Gustafson and Rutter., 1990; Schumacher et aI., 1991; Andersen et aI., 1992;
-
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Schumacher et aI., 1993). The type IIGF receptor binds IGF-It with a 2- to 15-
fold lower affinity and insulin with a 100 to 1000-fold lower affinity than for IGF-I
(Steel et aI., 1988; Germain Lee et aI., 1992; LeRoith et aI., 1995; Stewart and
Rotwein, 1996). The type I IGF receptor and insulin receptor are approximately
50 to 60% homologous overall, with 84% homology among the tyrosine kinase
domains (Czech, 1989). The type IIIGF, or IGF-lI/mannose-6-phosphate (IGF-
II/M6P) receptor is a single-chain membrane-spanning receptor (Lucy, 2000) that
functions to clear IGF-II from the cell surface, but does not appear to playa role
in the c1assicallGF actions such as mitogenesis (Monget et aI., 1996). Unlike the
type I receptor, the type II IGF receptor does not act via the c1assicallGF second
messenger pathway (Lucy, 2000) but acts by binding IGF-II, internalizing it via
endocytosis, and then degrading' it via intracellular Iysosomes (Oka et aI., 1985;
Nolan et aI., 1990; Braulke, 1999). The type II/M6P receptor binds IGF-II and
molecules with an M6P residue (Nissley and Kiess, 1991) with preferential
affinity, binds IGF-I with a 500-fold lower affinity than IGF-II and does not bind
insulin (Nissley et aI., 1991). Interestingly, the IGF-II binding site is distinctly
different than the binding site for mannose 6-phophate (Braulke et aI., 1988) and
both sites can be occupied simultaneously, however they can interfere with each
other (Kiess et aL, 1988; Oka et aI., 1985; Kiess et aI., 1990). Furthermore, the
extracellular domain of the type II/M6P IGF receptor can be cleaved by proteases
producing a soluable form that may act as a carrier of IGF-II (Clairmont and
Czech, 1991).
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Within the ovary, IGF receptors and IGF receptor mRNA have been found
to exist in porcine (Baranao and Hammond 1984; Otani et al., 1985), bovine
(Spicer et aL, 1994), rat (Davoren et aI., 1986) and human (EI-Roeiy et aI., 1993;
EI-Roeiy et aI., 1994) granulosa cells, as well as bovine (Stewart et aI., 1996), rat
(Hernandez et aI., 1988a,b) and human (Bergh et aI., 1993; EI-Roeiy et aI., 1993;
1994; Samoto et aI., 1993a,b) thecal cells. In addition, bovine (Sauerwein et aI.,
1992), rat (Ladenheim et aI., 1984; Parmer et aI., 1991; Talavera and Menon,
1991) and human (Samoto et aI., 1993a,b) luteal cells and human stromal cells
(Jarrett et aI., 1985; Poretsky et a!., 1988; Hernandez et aI., 1992) contain IGF
receptor mRNA and protein.
Type I receptors increase as granulosa cells develop and decrease during
atresia (Spicer and Echternkamp, 1995). Specifically, cultured bovine granulosa
cells from large follicles had a much greater number of IGF-I receptors than did
granulosa cells from small follicles (Spicer et aI., 1994) and IGF-I receptor activity
increased as follicles grew from preantral to antral size in bovine fetuses and
neonatal calves (Wandji et aL, 1992). However, numbers of IGF-I receptors in
granulosa and thecal cells do not differ between dominant and subordinate
bovine follicles (Stewart et aI., 1996). In rats, IGF-I receptor mRNA increased in
healthy follicles as granulosa cells differentiated and luteinized, but disappeared
from granulosa cells of atretic follicles (Zhou et aI., 1991). Furthermore, IGF-I
binding sites were significantly lower in atretic follicles than in nonatretic follicles
of mice (Baker et aI., 1996; Adashi: et aI., 1997; Wandji et al., 1998). In contrast,
granulosa celllGF receptor numbers remained constant among small, medium
-
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and large porcine follicles (Maruo et aL, 1988) and type IIGF receptor mRNA did
not change as follicles increased from 2 to 8 mm (preovulatory) in diameter in
weaned sows (Liu et aL, 1999).
Within granulosa cells, type IIGF-I receptors appear to be both
gonadotropin and estrogen dependent (for review see Adashi, 1998).
Specifically, FSH increases IGF I receptors in granulosa cells from small bovine
follicles (Spicer et aL, 1994). Furthermore. FSH and LH increases granulosa-cell
IGF-I receptor numbers in hypophysectomized DES treated rats (Adashi et aI.,
1986; Adashi et al., 1988). Estradiol treatment increases IGF-I receptor number
in cultured porcine granulosa cells (Veldhuis et aL, 1986). Similary, estradiol, but
not progesterone, stimulateslGF-1 receptor numbers in bovine granulosa cells
(Spicer et aL, 1994). However, in vivo, estradiol treatment decreases IGF-I
receptor numbers in rat corpora lutea (Parmer et aL, 1991). Thus, numbers of
granulosa-ceIlIGF-1 receptors are increased by FSH and(or) estradiol in all
species evaluated to date.
-
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CHAPTER III
Effect of Follicle Size on in vitro Production of Steroids and
Insulin-like Growth Factor (IGF)-I, IGF-II and the IGF
Binding-Proteins (IGFBPs) by Equine Ovarian Granulosa Cells
Abstract
The objectives of this study were to determine 1) if stage of the estrous
cycle or follicle diameter influences steroid concentration or components of the
IGF system present in follicular fluid of mares (Experiment 1), 2) if estradiol,
insulin and/or FSH affect steroid production by equine granulosa cells
(Experiment 2A), and 3) if the components of the IGF system are produced by
equine granulosa cells in culture, as well as whether estradiol, insulin and/or FSH
affects IGF and/or IGFBP production by equine granulosa cells (Experiment 2B).
Follicular fluid and granulosa cells from small «15 mm), medium (16-25 mm) and
large (>25 mm) follicles were collected from luteal (n=6) and follicular (n=8)
phase mares. Granulosa cells harvested from follicular fluid were cultured 2
days in medium containing 10% fetal calf serum, washed, and then treated for an
additional 2 days in serum-free medium with or without added hormones. In
Experiment 1, follicular fluid estradiol concentrations differed (p<0.05) with




not affected (p>0.1 0) by either estrous cycle stage or follicle diameter.
Concentrations of IGF-l did not differ (p>0.1 0) with estrous cycle stage, but
increased with follicle diameter (p<0.05). In comparison, IGF-H concentrations
differed (p<0.05) with estrous cycle stage, but did not differ.with follicle diameter
(p>0.10). IGFBP-2, -3, -4 and -5 appeared in mare follicular fluid, as well as
several high molecular weight IGFBPs. Levels of IGFBP-3 tended to differ
(p<0.08) with estrous cycle stage and increased with follicle diameter during the
follicular, but not luteal, phase. The remaining IGFBPs did not differ (p>0.1 0)
between phases, but IGFBP-2, -4, and -5 decreased with an increase in follicle
diameter (p<O.05), while a 125-135 kDa IGFBP tended to decrease with follicle
diameter (p<0.08). Levels of a 90-96 kDa IGFBP did not change (p>0.1 0) with an
increase in follicle diameter. In Experiment 2A, large follicles produced less
progesterone than did medium or small follicles (p<O.05). Progesterone
production was inhibited (p<O.05) by FSH and insulin in small and medium but
not large follicles; estradiol was without effect. Insulin increased (p<0.05)
estradiol production in small and medium follicle granulosa cells but had no effect
in large follicle granulosa cells. In Experiment 2B, IGF-I production was inhibited
(p<O.05) by insulin across all follicle sizes, but was not affected by estradiol or
FSH. Granulosa cells of medium and large follicles produced more IGF-II than
did granulosa cells of small follicles (p<O.05). Insulin and FSH inhibited (p<O.05)
IGF-II production by granulosa cells of large and medium but not small follicles;
estradiol was without effect. Of the four IGFBPs present in follicular fluid of
mares, IGFBP-2 and -5 were the only ones produced by equine granulosa cells.
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IGFBP-2 production was less (p<O.10) in granulosa cells of large vs small and
medium foHicles. Averaged across follicle sizes, estradiol increased (p<O.1 0)
IGFBP-2 production, whereas FSH increased (p<0.10) IGFBP-2 and -5
production; insulin was without effect. These results indicate that IGF-I,IGF-II,
IGFBP-2, -4 and -5 are present in equine follicle fluid and that estrous cycle
stage and follicle diameter influence concentrations of steroids and components
of the IGF system. Furthermore, these results indicate that IGF-I, IGF-II, IGFBP-
2 and -5 are produced by equine granulosa cells and that insulin, FSH and
estradiol playa role in the regulation of steroidogenesis and the IGF system of
equine granulosa cells.
Introduction
The insulin-like growth factor (IGF) system, composed of IGF-I, IGF-II, IGF
receptors and IGF-binding proteins (IGFBPs), plays an essential role in ovarian
function (for reviews see Sara and Hall, 1990; Hammond et aI., 1991; Giudice,
1992; Monget and Monniaux, 1995; Spicer and Echternkamp, 1995). In most
species, IGF-I stimulates granulosa and thecal cell proliferation and mitogenesis,
and synergizes with gonadotropins to stimulate granulosa and thecal cell
steroidogenesis (for reviews see Hammond et aI., 1991; Giudice, 1992;
Monniaux and Pisselet, 1992).
The IGFs are found in the systemic circulation bound to high affinity,
soluble, carrier proteins (for reviews see Baxter, 1988; Clemmons, 1993;
Rechler, 1993; Spicer and Echternkamp, 1995). These binding proteins have a
--
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greater affinity for the IGFs compared to IGF receptors and, therefore, are
thought to act as regulators of IGF availability for target cells (Baxter, 1988;
Clemmons, 1993). The presence of IGFBP mRNA in ovarian tissue was first
reported in 1989 (Margot et ai, 1989; Shimasaki et ai, 1989; Ui et ai, 1989) and
since that time additionallGFBPs (i.e., IGFBP-1 through - 8) have been identified
in the ovary of several species (for reviews see Rechler, 1993; Spicer and
Echternkamp, 1995). Within the follicle, IGFBP-3 levels do not change during
development, yet it is the most predominant IGFBP found in ovarian follicular
fluid of pigs (Mondschein et al., 1991; Echternkamp et aI., 1994b), cattle
(Echternkamp et aI., 1994a; Stewart et aI., 1996), sheep (Spicer et aI., 1995) and
horses (Gerard and Monget, 1998). In contrast, follicular fluid IGFBP-2, -4 and -5
activity is lower in growing (estrogen active) dominant vs. subordinate (estrogen
inactive) follicles in cattle (Echternkamp et aI., 1994a; Stewart et aI., 1996), pigs
(Grimes et ai, 1994b), sheep (Monget et aI., 1993) and horses (Gerard and
Monget, 1998). These studies suggest that follicular fluid IGFBP-2, -4 and -5
levels are closely related to the physiological status of follicles in several species.
Some of these IGFBPs are produced within the follicle by granulosa cells of pigs
and rats (for review see Spicer and Echternkamp, 1995). However, which
IGFBPs are produced by granulosa cells of the mare is unknown.
In the mare, one follicle is selected from a cohort of follicles to become
dominant. After selection the dominant follicle continues to grow until ovulation,
while the remaining cohort, or subordinate, follicles become atretic and regress
(for review see Ginther, 1992). Limited information is available regarding the
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physiological mechanism of follicle selection and maturation in the mare. During,
preovulatory development in the mare, follicular fluid IGF-I levels increase
(Spicer et aI., 1991) whereas IGFBP levels decrease (Gerard and Monget, 1998).
In cattle, it has been hypothesized that estradiol and the gonadotropins induce
changes in the amount of IGF-I and IGFBPs produced by granulosa and thecal
cells during follicular development (Spicer et aI., 1988; Spicer and Enright, 1991;
Stewart et aI., 1996). We hypothesize that, in the mare, follicular development
may involve steroid or gonadotropin induced changes in the intrafollicular IGF
system.
Therefore, the specific objectives of these experiments were to 1)
determine whether stage of the estrous cycle or follicle diameter influences
concentrations of steroids, as well as components of the IGF system, present in
follicular fluid of mares, 2) determine whether estradiol, insulin and/or FSH affect
steroid production by equine granulosa cells, and 3) determine what components
of the IGF system are produced by equine granulosa cells in culture, as well as
to determine whether estradiol, insulin and/or FSH affect IGF and/or IGFBP
production by equine granulosa cells.
Materials and Methods
Reagents and Hormones
The reagents used were as follows: Dulbecco's modified Eagle medium
(DMEM), Ham's F-12, sodium bicarbonate, gentamicin, insulin (bovine; 28.5
U/mg), trypan blue, fetal calf serum (FCS), estradiol and acrylamide, all obtained
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from Sigma Chemical Company (St, Louis, MO.); ovine FSH (F1913; FSH activity
15 x NIH-lH-S1 U/mg) obtained from Scripps Laboratories (San Diego, CA);
nitrocellulose transfer membrane (.45 j.1m pore size) obtained from Midwest
Scientific (S1. Louis, MO); protease-free bovine serum albumin (BSA) obtained
from Integrin (Purchase, NY); 20% (w/v) sodium dodecyl sulfate solution (SDS)
obtained from Amresco (Solon, OH); recombinant bovine IGF-II obtained from
Monsanto (S1. louis, MO).
Cell Culture
In late May, 1988, a total of 28 ovaries were obtained at a commercial
abattoir from 14 mares of various breeds, ages and sexual maturity. The mares
were classified as either in the luteal (n =6) or follicular (n =8) phase based on
gross ovarian morphology; ovaries with a viable (vasculature visible) corpus
luteum (CL) were classified as being in the luteal phase, and ovaries with large
follicles and a corpus albicans or regressing CL (as indicated by pale color and
little or no vascularity with a diameter < 20 mm) were classified as being in the
follicular phase (Ireland et aI., 1980). The ovaries were processed at the abattoir
(and in transit from the abattoir) as previously described for bovine follicles
(langhout et aI., 1991; Stewart et aI., 1995). Follicular fluid from individual
follicles were collected separately using needles and syringes. Specifically,
follicular fluid was aspirated from the follicle. Without removing the needle from
the follicle, follicular fluid was injected back into the follicle and aspirated out
again while the follicle was hand massag.ed to loosen granulosa cells. This was
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repeated two times per follicle. After granulosa cells were separated from
follicular fluid by centrifugation (220 X g for 5 to 7 min), individual follicular fluid
samples were frozen at -80 ac. Follicles were separated into three groups based
on surface diameter: small (6-15 mm), medium (16-25 mm) and large (25-48
mm) (Driancourt and Palmer, 1984). Granulosa cells from individual follicles were
combined into three pools within each of the three size categories without regard
to phase of cycle, washed twice in serum-free medium by centrifugation at 200 X
g (for 5 to 7 min) and resuspended in medium containing 1 mg/mL collagenase
and 0.01 mg/mL DNase to disperse and prevent clumping of the cells. The
number and viability granulosa cells was determined using a hemocytometer and
the trypan blue exclusion method, and averaged 74.9 ± 8.9%,79.2 ± 5.5% and
79.9 ± 10.98% of total granulosa cells, respectively from small, medium and large
follicles.
Medium consisted of a 1:1 (vol/vol) mixture of DMEM and Ham's F-12
containing 0.12 mM gentamicin, 20 mM glutamine and 38.5 mM sodium
bicarbonate. Approximately 4 X 105 viable cells in 100 ilL of medium were added
to Falcon 24-well plates (No. 3047; Becton Dickinson and Co., Lincoln Park, NJ)
containing 1 mL of medium with 10% FCS. Cultures were kept at 38.5°C in a
95% air-5% C02 atmosphere (Langhout et al. , 1991). Cell proliferation was
monitored daily using phase contrast microscopy. To obtain optimal attachment,
cells were maintained in 10% FCS without added hormones for the first 2 days of
culture. After 48 h, cells were washed twice with 0.5 mL of serum-free medium to
remove FCS and non-adherent cells, and incubations continued in serum-free
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medium (0.5 mL) containing 500 ng/mL of testosterone (as an estradiol
precursor) and 2.5 mg/mL of BSA (to minimize loss of the IGFBPs) with or
without added hormones for an add'tional 48 h. Throughout the 4-day culture,
medium was changed every 24 h.
Experiment 1 was designed to determine whether stage of the estrous
cycle or follicle diameter influenced concentrations of steroids and components of
the IGF system in mare follicular fluid. Follicular fluid was aspirated from follicles
as described earlier and assayed for concentrations of estradiol, progesterone,
androstenedione, IGF-I and IGF-II (see section on radioimmunoassays). Also,
follicular fluid was assessed for IGFBP activity based on molecular weight using
one dimensional, reducing sodium dodecyl sulfate polyacrylamide gel
electrophoresis (SDS-PAGE) (see later section on gel electrophoresis).
Experiment 2A was designed to determine whether estradiol, insulin
and/or FSH affected steroid production by equine granulosa cells. Granulosa
cells from small (6-15 mm), medium (16-25 mm) and large (25-48 mm) follicles
were cultured in medium containing 10% FeS for 48 h as described earlier. After
48 h, the media was replaced with serum-free medium containing testosterone
and either no hormone addition (control), estradiol (500 ng/mL), insulin (100
ng/mL). FSH (50 ng/mL), insulin (100 ng/mL) plus estradiol (500 ng/mL), or
insulin (100 ng/mL) plus FSH (50 ng/mL) and incubated for an additional 48 h. At
the end of the first 24 h incubation with treatments (Le., during day 2 to 3 of
culture) medium was collected for estradiol and progesterone measurement and
fresh medium was added.
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Experiment 2B was designed to determine what components of the IGF
system are produced by equine granulosa cells in culture, as well as to
determine whether estradiol, insulin and/or FSH affected IGF and/or IGFBP
production by granulosa cells. Granulosa cells from small (6-15 mm), medium
(16-25 mm) and large (25-48 mm) follicles were cultured as described in
Experiment 2A. Treatments were no additions (control), estradiol (500 ng/mL),
insulin (100 ng/mL), FSH (50 ng/mL), insulin (100 ng/mL) plus estradiol (500
ng/mL), or insulin (100 ng/mL) pi'us FSH (50 ng/mL). At the end of the second 24
hour incubation with treatments (Le., during day 3 to 4 of 'Culture) medium was
collected for IGF and IGFBP assessment.
Determination of Cell Numbers
After the treatment period had elapsed, medium from each well was
collected individually and frozen at (- 20°C) for later use. Numbers of granulosa
cells were determined at the termination of experiments (i.e., day 4 of culture)
using a Coulter counter (Model 2m; Coulter Electronics, Hialeah, FL) as
previously described (Saranao and Hammond, 1985; Langhout et aI., 1991).
Briefly, cells were exposed to 0.5 mL of trypsin (0.25%[wUvol] in 0.15 M NaCI) for
20 min at 25°C, then scraped from each well with a teflon policeman, diluted in
0.15 M NaCI and enumerated.
Concentration of Spent Medium
7]
Media samples collected for IGF and IGFBP assessment were
ultrafiltrated using Centricon concentrators with a molecular weight (MW) limit of
I
3,000 (Amicon, Inc., Beverly, MA). The spent medium was concentrated 5- to 18-
fold. Briefly, 400 J..lL of the spent media was placed inside the sample reservoir of
the concentrator and centrifuged at 5322 X g for approximately 80 min. After
centrifugation, the filtrate vial was discarded, the sample reservoir was inverted
and re-centrifuged for 5 min at 591 Xg to transfer the retentate into the retentate
vial. Final volumes ranging from 22 to 77J..lL were measured to record the
concentration factor of the sample; this value was used to correct IGF and IGFBP
data.
Protein Determination
Amount of protein in follicular fluid was quantified as previously described
(Lowry et aI., 1951). Assay sensitivity (i.e., the lowest value at 95% confidence
interval of the lowest point on the standard curve) was 1.79 J..l9/tube and the intra-
assay coefficient of variation was 15.0%.
Radioimmunoassays (RIA)
Progesterone RIA. Concentrations of progesterone in follicular fluid and in
culture medium collected 24 h after hormone treatments were determined with a
double-antibody RIA as previously described (Saranao and Hammond, 1985;
Langhout et aI., 1991). Assay sensitivity (i.e., 95% of total binding) was 0.016
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±0.007 ng/tube and intra- and interassay coefficients of variation were 12.9 and
17.5%, respectively.
Estradiol RIA. Concentrations of estradiol-17~ in follicular fluid and in
culture medium collected 24 h after hormone treatments were determined with a
double-antibody RIA as previously described (Spicer and Enright, 1991; Spicer
and Stewart, 1996). Assay sensitivity (Le., 90% of total binding) was 0.29 ± 0.05
pg/tube, and the intra- and interassay coefficients of variation were 12.5 and
10.4%, respectively.
Androstenedione RIA. Concentratiions of androstenedione in follicular
fluid were determined using solid-phase RIA kits (ICN Biomedicals, Costa Mesa,
CA) as previously described (Stewart et aI., 1995). Assay sensitivity (Le., 95% of
total binding) was 1.45 ± 0.36 pg/tube and the intra- and interassay coefficients
of variation were 15.0 and 17.0%, respectively.
IGF-I RIA. Concentrati:ons of IGF-I in follicular fluid and in concentrated
culture medium collected 48 h after hormone treatments were determined with a
double-antibody RIA aft.er acid-ethanol extraction (16 h at 4°C) as previously
described (Echternkamp et aI., 1990; Spicer et aI., 1991). Assay sensitivity (i.e.,
95% of total binding) was 4.89 ±0.72 ng/tube and the intra- and interassay
coefficient of variation was 14.5 and 18.8%, respectively.
IGF-II RIA. Concentrations of IGF-II in follicular fluid and in concentrated
culture medium collected 48 h after hormone treatments were determined with a
double-antibody RIA as previously described for bovine and ovine follicular fluid
(Spicer et aI., 1995; Stewart et aI., 1996) and validated for equine follicular fluid.
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Increasing volumes of extracted equine follicular fluid as well as concentrated
spent culture medium from equine granulosa ceU cultures created displacement
curves parallel to the standard curve. Assay sensitivity (i.e., 95% of total binding)
was 22.98 ± 9.40 pg/tube, and intraassay coefficient of variation was 9.17%.
Gel Electrophoresis of IGFBPs
IGFBPs in follicular fluid and concentrated culture medium collected 48 h
after hormone treatment were analyzed by one-dimensional, reducing, SDS-
PAGE based on molecular weight as previously described (Echternkamp et aI.,
1994a; Simpson et aI., 1997). Briefly, for culture medium, 12.5 I!L of
concentrated sample was mixed with 12.5 I!L of Laemmli sample buffer
(BIORAD, Hercules, CA). For follicular fluid, 4 I!L of sample was mixed with 21
I!L of Laemmli sample buffer (BIORAO, Hercules, CA). The samples were heat
denatured (3 min at 100°C), centrifuged at 4657 X g for 3 min and then
electrophoresed on a 12% polyacrylamide gel overnight (approximately 18 to 20
h) at a constant current (25 to 35 amps) and varying voltage. After separation,
proteins in gels were electrophoretically transferred to nitrocellulose paper
(Midwest Scientific, St. Louis, MO) for 2.5 to 3.0 h. Each nitrocellulose paper was
incubated with 6 mL of 1251_IGF_1I (15,000 cpm/100 I!L) and placed on a rocking
platform at 4°C overnight. The next day, the blots were washed in a Tris-buffered
saline (TBS) with 0.1 % Tween followed with additional washings with only the
TBS. The nitrocellulose blots were then dried and exposed to X-ray film at (-80
°C) for 12 days for follicular fluid and 4 days for culture medium. Individual band
"
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intensity on autoradiographs was densitometrically analyzed using a Molecular
Analyst (BIORAD, Hercules, CA).
Statistical Analysis
Data were analyzed using PROC MIXED of SAS. For Experiment 1, linear
regressions were performed for each response variable (E2, P4, ~, protein, IGF-
I, IGF-II and IGFBPs) using the variable "SIZE" as the independent variable.
Separate regressions were performed for each stage (Luteal or Follicular).
Dummy variables for each response were used to assess whether the slopes
associated with each stage were significantly different. If the slopes associated
with the two stages were not statistically significant, then a model to assess the
difference in the intercepts f0r the two stages was performed. For Experiment 2A
and 2B interaction of size by treatment was assessed. In the absence of
interaction, orthogonal contrasts to assess the main effects of estradiol, FSH and
insulin were utilized. In the presence of interaction, contrasts were formed to
evaluate the simple effects of estradiol, FSH and insulin on each follicle size.
Multiple mean comparisons (LSD) were performed only if a main effect was
significant. For Experiment 28, correction factors were utilized to standardize
volume of concentrated media.
Results
Experiment 1: Effect of stage of estrous cycle and follicle diameter on
steroid concentrations and the IGF system in equine follicular fluid.
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Estradiol production differed during the follicular phase as. compared to the
luteal phase (p<0.05). Fitted ines for both the follicular and luteal phases are
shown in Figure 1. During the follicular phase, estradiol concentration increased
with an increase in follicle diameter (p<0.05). In contrast, diameter appeared to
play little or no role in increasing estradi.ol concentration during the luteal phase
(p>0.10). In contrast to estradiol, progesterone concentration in follicular fluid
averaged 28.9 ± 3.8 ng/mL and did not differ (p>O.10) between the follicular and
luteal phase, nor was it affect.ed (p>0.1 0) by follicle diameter (data not shown).
Androstenedione concentration in follicular fluid averaged 80.09 ± 28.43
ng/mL and did not differ (p>0.1 0) between the follicular and luteal phase.
However, androstenedione concentration increased as follicle diameter
increased (p<0.05). The fitted line for the combined follicular and luteal phases of
androstenedione are shown in Figure 2.
The concentration of protein found in follicles of the follicular phase was
different (p<0.05) than that seen in luteal phase follicles. During both phases of
the estrous cycle, protein concentrations increased with an increase in follicle
diameter (p<O.05; data not shown).
Concentrations of IGF-I in follicular fluid during the follicular phase (45.9 ±
4.7 ng/mL) did not differ (p>O.1 0) from those during the luteal phase (34.1 ± 5.6
""
ng/mL). However, IGF-I concentration increased as follicle diameter increased
(p<0.05). The fitted line for the combined follicular and luteal phases of IGF-I are
shown in Figure 3. Unlike IGF-I, IGF-II concentrations were different (p<O.05)
between the follicular (61.4 ± 3.6 ng/mL) and lutea.1 (51.3 ± 4.3 ng/mL) phase, but
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IGF-II concentrations remained similar (p>O.10) as follicle diameter increased
(data not shown).
Of the known IGFBPs, IGFBP-2, -3, -4 and -5 were present in mare
follicular fluid (Figure 4). We also detected severallGFBPs with estimated
molecular weights ranging between 90 and 135 kDa. Levels of IGFBP-3 tended
to differ (p<0.08) between the follicular and luteal phases and increased (p<0.05)
with an increase in follicle diameter during the follicular stage but not the luteal
phase. The fitted lines for IGFBP-3 of both follicular and luteal phases are shown
in Figure 5. In contrast, the other IGFBPs did not differ (p>O.10) between phases
(data not shown). IGFBP-2, -4 and -5 decreased (p<O.05) with an increase in
follicle diameter (Figure 6). The 125-135 kDa IGFBP and the 115 kDa IGFBP
tended to decrease (p<O.08) with an increase in follicle diameter (data not
shown). Concentrations of the 90-96 kDa IGFBP did not change (p>0.1 0) with
follicle diameter (data not shown).
Experiment 2A: Effect of insulin, FSH and estradiol on granulosa cell
steroid production
Basal levels of progesterone production were lower (p<0.05) in large-
versus small- and medium-follicle granulosa cells (Figure 7). Progesterone
production was inhibited (p<0.05) by insulin, FSH, and a combination of insulin
plus FSH in cultures of small- and medium- but not large-follicle granulosa cells.
Estradiol alone had no effect (p>0.10) on progesterone production in medium-
and large-follicle granulosa cells, but inhibited (p<O.05) progesterone production
77
in small-follicle granulosa ceHs. When estradiol was combined with insulin,
progesterone production was inhibited (p<0.05) in cultures of small- and medium-
but not large-follicle granulosa cells; this inhibition was similar to that seen with
insulin alone (Figure 7).
Basal levels of estradiol production did not differ (p>0.05) in cultures of
small-, medium- or larg,e-follicle granulosa cells (Figure 8). Insulin stimulated
(p<0.05) estradiol production by small- and medium-follicle granulosa cells, but
was without effect (p>0.1 0) in large follicles. FSH treatment alone had no effect
(p>0.10) on estradiol production by smal:l- and large-follicle granulosa cells, but
inhibited (p<0.05) estradiol: production by 90% in medium follicles. FSH also
inhibited (p<0.05) the insulin-induced increase in estradiol production by medium
follicles. In small follicles, the combined treatment of insulin and FSH stimulated
(p<0.05) estradiol production 5-f()ld compared to controls and 8-fold compared to
FSH treated cultures; granulosa cells of large follicles were not affected (p>0.10)
by the insulin and FSH combination (Figure 8).
Experiment 28: Effect of insulin, FSH and estradiol on granulosa cell IGF
and IGFBP production
Equine granulosa cells produced 10- to 50-fold more IGF-II (Figure 9) than
IGF-I (Table 1) in culture. When averaged across follicle size, insulin inhibited
(p<0.05) IGF-I production 24% to 36%, but was not affected by estradiol or FSH
(Table 1). In comparison, singular treatments of insulin or FSH inhibited (p<0.05)
IGF-II production by medium- and large- but not small-follicle granulosa cells
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(Figure 9). Combined treatments of insulin plus FSH also inhibited (p<0.05) IGF-
II production by medium- and large- but not small-follicle granulosa cells; this
inhibition by combined treatments did not differ (p>0.1 0) from either singular
treatment. Estradiol alone inhibited (p<0.05) IGF-II production by large-follicle
granulosa cells but had no effect in small or medium follicles. Medium- and
large-follicle granulosa cells produced more (p<0.05) basallGF-1I than did small-
follicle granulosa cells (Figure 9).
Equine granulosa cells produced two forms of IGFBP: a 29-40 kDa IGFBP
(IGFBP-2) and a 29-31 kDa IGFBP (IGFBP-5; Figures 10, 11 and 12). Size of
follicle did not influence (p>O.1 0) production of IGFBP-5; however IGFBP-2
production by granulosa cells of large follicles tended (p<0.10) to be 35% to 59%
less than small and medium follicles. Treatment tended (p<0.10) to affect both
IGFBP-2 and IGFBP-5 production (Table 1). When averaged across follicle size,
estradiol increased (p<0.10) only IGFBP-2 production, whereas FSH increased
(p<0.10) both IGFBP-2 and IGFBP-5 production. Insulin alone was without effect
(p>0.10) on IGFBP-5 production, but tended (p<0.06) to increase IGFBP-2
production in large follicles and decrease IGFBP-2 production in medium and
small follicles (data not shown). Insul'in combined with either estradiol or FSH
blocked (p<O.10) the stimulatory effect of estradiol on production of IGFBP-2 and
the stimulatory effect of FSH on production of IGFBP-5 (Table 1).
Representative examples of cultured equine granulosa cells from small,
medium and large follicles are depicted in Figures 10, 11 and 12. Insulin
stimulated (p<0.05) granulosa cell numbers in cultures from small and medium
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follicles, but was without effect in cultures from large follicJes (Figure 13).
Estradiol and FSH treatments alone had no effect (p>O.10) on granulosa cell
numbers in cultures from small, medium or large follicles. When estradiol or FSH
was combined with insulin, granulosa cell numbers increased (p<O.05); these
increases were similar to those seen with insulin alone (Figure 13).
Discussion
Results of the present study revealed that 1) follicular fluid levels of
IGFBP-2, -4 and -5 decreased with follicular size whereas levels of estradiol and
IGFBP-3 increased with follicular size, 2) of the IGFBPs found in follicular fluid
only IGFBP-2 and -5 are produced by equine granulosa cells, 3) FSH and
estradiol increased IGFBP-2 and -5 production, had no effect on IGF-I
production, and decreased IGF-II production by equine granulosa cells, and 4)
estradiol and progesterone production by equine granulosa cells were
differentially regulated by insulin and FSH and these effects were dependent on
follicle size.
In the present study, intrafollicular levels of the low molecular weight
IGFBPs (IGFBP-2, -4 and -5) decreased as follicle diameter increased
regardless of estrous cycle stage in the mare. This result is consistent with those
obtained from cyclic pony mares in which IGFBP-2 binding activity decreased
during growth of the dominant follicle but was substantially increased in
subordinate cohort follicles (Gerard and Monget, 1998). Similarly, intrafollicular
levels of IGFBP-2 and -4 in pigs (Yuan et aI., 1996) and IGFBP-2, -4 and -5 in
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sheep (Monget et aI., 1993; Spicer et aI., 1995) and cattle (Echternkamp et aI.,
1994a; Stewart et aI., 1996) significantly decrease as follicle diameter increases
probably due to a decrease in gene expression (Samaras et al., 199:2; Besnard
et aI., 1996a,b; Armstrong et aI., 1998), an increase in proteolytic degradation of
the binding proteins (Besnard et aI., 1'996b; Besnard et aI., 1997) or both. Unlike
the low molecular weight IGFBPs, we found that IGFBP-3 levels were unchanged
as follicle size increased during the follicular phase but increased with an
increase in follicle size during the luteal phase. Increases in follicular fluid IGFBP-
3 with increased follicle size have been observed in some studies with sheep
(Monget et aI., 1993) and pigs (Grimes et aI., 1994b). However, other studies
report that IGFBP-3 does not change with follicle size in pigs (Howard and Ford,
1992; Echternkamp et aI., 1994b), humans (Cataldo and Giudice, 1992), sheep
(Monget et aI., 1993; Spicer et aI., 1995) and cattle (Echternkamp et aI., 1994a;
Funston et aI., 1996; Stewart et al., 1996). Gerard and Monget (1998) found that
follicular fluid IGFBP-3 content does not change in equine follicles ranging from
22 mm in diameter to preovulatory size (> 35 mm). This latter ob.servation is not
inconsistent with the present study because the lowest levels of IGFBP-3 were
found in follicles < 10 mm (Figure 3).
Previous findings are consistent with our observations that intrafollicular
estradiol increases during follicular growth (Meinecke et al., 1987; King and
Evans, 1988; Sirois et aL, 1990; Gerard et aI., 1998; Gerard and Monget, 1998;
Goudet et aI., 1999). Van Rensburg and Van Niererk (1968), using 16 follicles,
noted increases in follicular fluid estradiol concentrations with increases in
&1
diameter of follicles> 20 mm. Similarly, our results indicate that concentrations
of estradiol do not dramatically increase until follicles reach> 25 mm in diameter.
Gerard and Monget (1998) indicated that an increase in estradiol levels occur
from early dominant (22-25 mm) follicles to late dominant (33-35 mm) follicles.
Similarly, Belin and coworkers (2000) found that estradiol levels were lower in
dominant follicles at emergence (approximately 20 mm in diameter) than at the
end of follicular growth (~ 30 mm in diameter) or in preovulatory follicles.
Aromatase activity dramatically increases from 20-24 mm follicles to 25-29 mm
follicles at the end of the follicular phase (Goudet et aI., 1999). Collectively, the
past and present research suggests that as follicles develop and become
estrogen active, IGFBP-2, -4, and -5 decrease whereas IGFBP-3 remains
constant or increases creating a total net decrease in IGFBP activity. In the mare,
this decrease in net IGFBP activity concomitant with an increase in total IGF-I
levels may act to increase the amount of free IGF-I within the follicle and
subsequently increase the sensitivity of the follicle to gonadotropins, stimulating
granulosa cell differentiation and follicular development. Those follicles showing
increased levels of the low molecular weight IGFBPs and decreased estradiol
may be destined for atresia (Giudice, 1992; Monget and Monniaux, 1995;
Armstrong et aI., 1996; Monget et aI., 1996).
For the first time, IGFBP production by equine granulosa cells has been
evaluated. Of the IGFBPs detected in equine follicular fluid (IGFBP-2,
-3, -4 and -5), only IGFBP-2 and -5 were produced by equine granulosa cells,
and both were responsive to hormone treatment. Previous research suggests
82
that granulosa cell production of IGFBPs is highly species specific. For example,
a 29 kDa (presumably IGFBP-1) is produced by ovine granulosa ceUs, as well as
IGFBP-2 and -5 (Armstrong et aI., 1996). Granulosa cells from mice (Adashi et
aI., 1997) and cattle (Chamberlain and Spicer, 1998) produce IGFBP-2, -4 and-
5 and porcine granulosa cells produce IGFBP-2, -4 and -5, as well as IGFBP-3
(Grimes et a\., 1994a). In the present study, we determined that follicle size had
no influence on IGFBP-5 production, but IGFBP-2 production tended to be 35%
to 59% less in large- vs. small- and medium-follicle granu,losa cells. The present
study also revealed that FSH and estradiol treatments increased IGFBP-2 and-5
production by equine granulosa cells. These results are in contrast with studies in
pigs (Mondschein et aI., 1990; Grimes et aI., 1992) that found FSH to be one of
the most potent inhibitors of IGFBP-2. Simarlily, FSH has been observed to
inhibit granulosa cell IGFBP-2 production in rats (Bicsak et aI., 1990) and IGFBP-
2 mRNA in cattle (Armstrong et aI., 1998; Schams et aI., 1999) but did not effect
IGFBP-2 production in human luteinizing granulosa cells (Cataldo et aI., 1993) or
ovine granulosa cells (Monget et aI., 1998). In comparison, estradiol inhibits
granulosa ceIlIGFBP-2 production in rats (Ricciarelli et aI., 1991) and pigs
(Mondschein et aI., 1990), but increases plasma IGFBP-5 levels in cattle
(Simpson et aI., 1997). In the mare, granulosa cell production of IGFBP-2 and -5
may play an inhibitory role on IGF-I action in follicular cells as reported in other
species (Liu et aI., 1993; Spi.cer et aI., 1997; Spicer and Chamberlain, 1999).
High expression of these binding proteins within a follicle may limit free IGF-I,
thus slowing follicular growth and allowing emergence of a dominant follicle
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(Stewart et ai., 1996; Adashi, 1998). Therefore, inhibition of intrafollicular
production of IGFBP-2 and -5 may be necessary, at least in part, for selection of
the dominant follicle in the mare.
Similar to what was observed in the present study, follicular fluid levels of
IGFBP-2 decrease with increases in estradiol concentrations in humans (San
Roman and Magoffin, 1993), cattle (Echternkamp et aI., 1994a; Funston et al.,
1996; Stewart et ai., 1996), pigs (Howard and Ford, 1992), and sheep (Spicer et
ai., 1995). Therefore, it is likely that follicular fluid levels of IGFBP-2, -4 and -5
are initially high at follicular emergence due to increases granulosa cell
production in response to high levels of FSH in circulation. When follicles reach
approximately 20 mm in diameter, just prior to selection of the dominant follicle in
the mare (for review see Ginther, 2000), follicular fluid levels of IGFBP-4 and -5
begin to decrease most probably due to actions of specific IGFBP proteases
concomitant with the increase in intrafollicular estradiol and the decline in FSH. In
response to declining FSH levels, granulosa cell production of IGFBP-2 and-5
slows. Once the dominant follicle has been selected, estradiol levels increase,
further stimulating granulosa cell IGFBP-2 and -5 production in atretic, cohort
follicles.
For the first time, hormonal regulation of equine granulosa cell derived
IGFs was observed. The present study revealed that FSH and estradiol
treatment had no effect on IGF-I production but decreased IGF-II production by
equine granulosa cells. Also, insulin and FSH inhibited IGF-II production by





production by small-fol!licle granulosa cells is unresponsive to trophic factors in
the mare. In comparison to our findings, FSH tfieatment has no effect on IGF-I
production by bovine granulosa cells (Spicer et aI., 1993; Spicer and
Chamberlain, 2000a), but stimulates IGF-I production by porcine granulosa cells
(Hsu and Hammond, 1987a,b; Mondschein et aI., 1988). In humans, FSH
stimulates IGF-II, but not IGF-I, production and mRNA by granulosa cells
(Ramasharma and Li, 1987). In bovine granulosa cells, estradiol enhances the
insulin-induced decreases in IGF-I and IGF-II production but has no effect on
basallGF-1 and IGF-II production (Spicer and Chamberlain, 2000a,b). However,
in cultured ovine (Wathes et aI., 1995) and porcine (Hsu and Hammond, 1987b)
granulosa cells, estradiol increases IGF-I production and in vivo treatment of
immature hypophesctomized rats with DES increases IGF-II mRNA, but
decreases IGF-II mRNA within the ovary (Hernandez et aI., 1990). Thus, species
differences may exist in regard to hormonal control of ovarian IGF production.
The present study also revealed that estradiol and progesterone
production by equine granulosa cells were differentially regulated by insulin and
FSH. We found that insulin decreased progesterone production but increased
estradiol production in small- and medium-, but not large-follicle granulosa cells.
Similarly, insulin stimulates estradiol production by small-follicle bovine granulosa
cells (Spicer et aI., 1993; Spicer et aI., 1994; Spicer and Chamberlain, 1998), but
has no effect or decreases estradiol production in pigs (small vs large follicles;
Veldhuis et aI., 1983; Maruo et aI., 1988), and humans (Erickson et aI., 1990).
However, insulin and FSH stimulates progesterone production by granulosa cells
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of cattle (Schams et aI., 1988; Spicer et aI., 1993), swine (Saranao and
Hammond, 1984), and rats (Davoren et aI., 1986). We also observed that FSH
alone decreased progesterone production by small- and medium-, but had no
effect on large-follicle granulosa cells. Why insulin and FSH are inhibitory to
progesterone production in mares but stimulatory in other species remains to be
elucidated, but may involve some species specific mechanism unique to the
mare. FSH alone did not affect estradiol production by small- and large-follicle
granulosa cells, but decreased estradiol production by 90% in medium-fol·licle
granulosa cells. However, in the presence of insulin, FSH enhanced the
stimulatory effect of insulin on estradiol production by small follicle granulosa
cells, and inhibited the stimulatory effect of insulin on estradiol production by
medium-follicle granulosa cells. Sirois et al. (1991) reported that in the presence
of insulin, FSH was unable to stimulate estradiol production in large equine
follicles during the early estrous phase but was able to significantly stimulate
progesterone production by granulosa cells from large (early and late estrus
stage) follicles. Also, equine granulosa cell responsiveness to FSH in terms of
estradiol and progesterone production decreased as follicle diameter increased
in early to late estrus follicles (39 to 47 mm; Sirois et aI., 1990), which is constant
with results of the present study. Therefore, high circulating levels of FSH, as
seen during early follicular growth, may act to inhibit premature granulosa cell
differentiation and/or luteinization in small and medium follicles as indicated by
the decreased levels of prog;esterone and estradiol in the present study. Once
follicles reach a large diameter (> 25 mm) FSH receptors may be downregulated
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making these follicles unresponsive to FSH. Further research is needed to
under~tand hormonal regulation of granulosa cell steroidogenesis in the mare.
The present study indicates that IGF-I, IGF-II, IGFBP-2, -4 and -5 are
present in equine folncle fluid and that estrous cycle stage and follicle diameter
influence concentrations of steroids and components of the IGF system.
Furthermore, these results indicate that IGF-I, lGF-II, IGFBP-2 and -5 are
produced by equine granulosa cells and that insulin, FSH and estradiol playa
role in the regulation of steroidogenesis and the IGF system of equine granulosa
cells. The present study suggests that decreased levels of low molecular weight
IGFBPs in large estrogen-active follicles may allow an increase in free IGF-I and
thus increase gonadotropin responsiveness and growth of the future dominant
follicle. In contrast, increased levels of the low molecular weight IGFBPs in small
cohort follicles may act to sequester IGF-I causing a low responsiveness to IGF-I
and FSH, thus slowing growth rate of future subordinate follicles.
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Figure 1. Linear regression analysis of estradiol concentration in follicular fluid.
Estradiol concentration in follicles during the follicular phase (--) is
represented by the line y = 59.62x - 740.71. Estradiol concentration
in follicles during the luteal phase ( - - - ) is represented by the
line y = 16.40x - 163.21.
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Figure 2. Linear regression analysis of androstenedione concentration in
follicular fluid. Androstenedione concentration did not differ between
follicular and luteal phases and is represented by the
line y = 11.74x - 107.03.
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Figure 3. linear regression analysis of IGF-I concentration in
follicular fluid. IGF-I concentration did not differ between
follicular and luteal phases and is represented by the
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Figure 5. Linear regression analysis of IGFBP-3 concentration in follicular fluid.
IGFBP-3 concentration in follicles during the follicular phase (--) is
represented by the line y = 0.44x + 37.11. IGFBP-3 concentration
in follicles during the luteal phase ( - - - ) is represented by the
line y =1.83x + 18.77.
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Figure 6. Linear regression analysis of IGFBP-2, -4 and -5 concentrations in
equine follicular fluid. In each panel, the regression line represents IGFBP
concentration during the combined follicular and luteal phases.
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Figure 7. Effects of insulin (100 ng/mL), estradiol (500 ng/mL), and/or FSH
(50 ng/mL) on progesterone production by granulosa cells collected
from small (6 to15 mm), medium (16 to 25 mm), and large (25 to 48 mm)
follicles of mares. Pooled SEM = 5.0 ng/105 cells/24 h.
a, b, C Within a follicle size, means without a common superscript differ (p<O.05),





















Figure 7. Effects of insulin (100 ng/mL) and/or FSH (50 ng/mL) on estradiol
production by granulosa cells collected from small (6 t015 mm), medium
(16 to 25 mm), and large (25 to 48 mm) follicles of mares.
Pooled SEM = 539 pg/105 cells/24 h.
a, b, C Within a follicle size, means without a common superscript differ (p<0.05).





















Figure 9. Effects of insulin (100 ng/mL), estradiol (500 ng/mL), and/or FSH
(50 ng/mL) on IGF-JI production by granulosa cells collected from
small (6 to15 mm), medium (16 to 25 mm). and large (25 to 48 mm)
follicles of mares. Pooled SEM = 1.2 ngl1 05 cells/24 h.
a, b Within a follicle size, means without a common superscript differ (p<0.05).





Figure 10. Panel A: representative ligand blot of IGFBP production by
equine granulosa cells from small follicles. Treatments were as follows:
lanes 1 and 2 =control, lanes 3 and 4 =estradiol, lanes 5 and 6 =
insulin, lane 7 =estradiol+insulin, lane 8 =FSH, lane 9 =FSH+insulin.
Panel 8: representative example of control cultures of equine granulosa
cells from small follicles under phase contrast microscopy (200x). Panel
C: representative example of insulin treated cultures of equine granulosa
cells from small follicles under phase contrast microscopy (200x).






Figure 11. Panel A: representative ligand blot of IGFBP production by
equine granulosa cells from medium follicles. Treatments were as
follows: lane 1 =control, lane 2 =estradiol, lane 3 =insulin, lanes 4 and
5 =estradiol+insulin, lanes 6 and 7 =FSH, lanes 8 and 9 =FSH +
insulin, lane 10 = equine follicular fluid, lane 11 = no sample, lane 12 =
bovine follicular fluid. Panel B: representative example of control cultures
of equine granulosa cells from medium follicles under phase contrast
microscopy (200x). Panel C: representative example of insulin treated
cultures of equine granulosa cells from medium follicles under phase
contrast microscopy (200x).




Figure 11. Panel A: representative ligand blot of IGFBP production by
equine granulosa cells from large follicles. Treatments were as follows:
lane 1 = control, lane 2 = estradiol, lane 3 = insulin, lanes 4 and 5 =
estradiol+insulin, lanes 6 and 7 = FSH, lanes 8 and 9 = FSH+insulin.
Panel B: representative example of control cultures of equine granulosa
cells from large follicles under phase contrast microscopy (200x). Panel
C: representative example of insulin treated cultures of equine granulosa
cells from large follicles under phase contrast microscopy (200x).
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Figure 9. Effects of insulin (100 ng/mL), estradiol (500 ng/mL), and/or FSH
(50 ng/mL) on granulosa cell numbers from small (6 to15 mm).
medium (16-25 mm), and large (25 to 48 mm) follicles of mares.
Pooled SEM = 1.2 ng/1 05 cells/24 h.
a, b Within a follicle size, means without a common superscript differ (p<O.05).
Table 1











1 Because follicle size was not significant, data were pooled across follicle sizes
2 units = ng/1 05 cells/24 h; pooled SEM = 0.05.
3 units =ADU/1 05 cells/24 h; pooled SEM =0.43; ADU =arbitrary densitometric
units.
4 units =ADU/1 05 cells/24 h; pooled SEM =0.10.
a, b Within a row, means without a common superscript differ (p<O.05).
c, d Within a row, means without a common superscript differ (p<O.10).
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CHAPTER IV
SUMMARY AND CONCLUSIONS
Folliculogenesis is a complex process involving the interaction of a
multitude of factors. During the estrous cycle of the mare, one follicle is selected
from a cohort of follicles to become dominant, while the remaining cohort, or
subordinate, follicles become atretic and regress. During preovulatory
development in the mare, follicular fluid IGF-Ilevels increase whereas IGFBP
levels decrease. In cattle, it has been hypothesized that estradiol and the
gonadotropins induce changes in the amount of IGF-I and IGFBPs produced by
granulosa and thecal cells during follicular devlopment. However, one question
remains: what factors determine selection of the follicle?
The present study evaluated cultured equine granulosa cells to determine
intrafollicular production and hormonal regulation of the insulin-like growth factor
system and steroidogenesis in equine follicles in relation to follicle size and
estrous cycle stage. IGF-I, IGF-II, IGFBP-2, -4 and -5 were present in equine
follicle fluid and both stage of the estrous cycle and follicle diameter influenced
concentrations of steroids and components of the IGF system. Furthermore,
IGF-I, IGF-II, IGFBP-2 and -5 were produced by equine granulosa cells and
steroidogenesis and(or) thelGF system of equine granulosa cells were
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differentially regulated by FSH and estradiol. The conclusion to obtain from this
work is that the insulin-like growth factor system and steroidogenesis are
hormonally regulated in equine follicles. Decreased levels of low molecular
weight IGFBPs in large estrogen-active follicles may allow an increase in free
IGF-I and thus increase gonadotropin responsiveness and growth of the future
dominant follicle. In contrast, increased levels of the low molecular weight
IGFBPs in small cohort follicles may act to sequester IGF-I causing a low
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